Facebook
X
LinkedIn
ForwardUWNIL 7th Floor Education Summit Sessions 2026
Overview
This course provides participants with up-to-date education on the latest evidence-based practice initiatives to enhance clinical decision-making and patient care. Learners will explore new, evolving, high-risk, and low-volume practices relevant to their field. The curriculum includes hands-on training in BLS/CPR and AED usage, safe chemotherapy administration and documentation, and the selection and use of appropriate safe patient handling equipment.
Format: Live In-Person
This session is scheduled to be held in person at UW Health SwedishAmerican Hospital, 401 E. State St., Rockford, IL 61104.
Elements of Competence
This activity has been designed to change learner competence and focuses on the following competencies:
American Board of Medical Specialties
- Patient care and procedural skills
- Practice-based learning and improvement
Social Belonging
Intended Audience
This activity is designed to meet the educational needs of nurses.
Learning Objectives
As a result of this activity, participants, as members of the healthcare team will be able to:
- Demonstrate skills and care related to best practice guidelines for the 7th floor patient population
- Explain unit-specific requirements and procedures
See the individual session pages for agendas and accreditation information.
Planners
Julie Gates, MSN
Nursing Professional Development Specialist
Angela Villarreal, MSN
Manager-Surgical Oncology
Marisela Carrillo-Hernandez, BSN
Staff Nurse-Surgical Oncology
Peggy Kidd
Patient Care Technician-Surgical Oncology
Policy on Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate, and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE). In addition, speakers, presenters, and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved uses of drugs/devices in presentation? |
| Julie Gates | Chair/Activity Coordinator | No relevant relationships with ineligible companies to disclose | No |
| Angela Villarreal | Planner/Presenter | No relevant relationships with ineligible companies to disclose | No |
| Marisela Carrillo-Hernandez | Planner/Presenter | No relevant relationships with ineligible companies to disclose | No |
| Peggy Kidd | Planner | No relevant relationships with ineligible companies to disclose | No |
*Ineligible companies are those whose primary business is producing, marketing, selling, re‐selling, or distributing healthcare products used by or on patients.
The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.